reports
Nuvectra® Continuing to Support Current Patients with the Algovita® ...
Nuvectra® Continuing to Support Current Patients with the Algovita® Implant as Company Voluntarily Files for Chapter 11 Court-Supervised Process Has No Impact on Safety or Functionality of Algovita Device; Company Continuing to Support Physicians PLANO, Texas, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR) (“Nuvectra” or the “Company”), a neurostimulation medical device company, today announced that it has elected to file a voluntary petition for reorganization under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the Eastern Distr...
Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA...
Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA for Virtis™ PLANO, Texas, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced it has submitted supplementary chemical composition and biocompatibility data to the U.S. Food and Drug Administration (FDA) in support of the Company’s Virtis pre-market approval (PMA) application for the treatment of chronic urinary retention and symptoms of overactive bladder. Fred Parks, Chief Executive Officer, commented, “In April of this year, the FDA reque...
Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer
Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer PLANO, Texas, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Jennifer Kosharek as Chief Financial Officer, effective September 16, 2019. Ms. Kosharek will assume the role of Chief Financial Officer after having served as the Company’s interim Chief Financial Officer since May 2019, leveraging over fifteen years of audit and accounting experience and various finance and leadership positions within Nuvectra. Dr. Fred Parks, ...
Nuvectra® Exploring Strategic Options to Enhance Shareholder Value
Nuvectra® Exploring Strategic Options to Enhance Shareholder Value PLANO, Texas, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that its Board of Directors has decided to explore potential strategic alternatives to enhance shareholder value. The Company is currently evaluating all options, including a sale or merger of the Company, to finance the expected growth of the Nuvectra business. Anthony Bihl, Chairman of the Board, commented, "We are thankful to our employees for their hard work in support of ou...
Nuvectra® Reports Second Quarter 2019 Financial Results
Nuvectra® Reports Second Quarter 2019 Financial Results PLANO, Texas, July 31, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended June 30, 2019. Recent Business Highlights Algovita® revenues increased 7% year-over-year to $12.3 millionFiled regulatory submission with FDA for Algovita full-body MR conditional approvalHighlighted positive preliminary Algovita clinical data at the INS 14th Annual World CongressRevised full year 2019 Algovita revenue guidance to $50-55 millio...
Nuvectra to Report Second Quarter 2019 Financial Results on July 31, 2...
Nuvectra to Report Second Quarter 2019 Financial Results on July 31, 2019 PLANO, Texas, July 17, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended June 30, 2019 on Wednesday, July 31, 2019 after market close. Nuvectra will hold a conference call on Wednesday, July 31, 2019 at 4:30pm ET to discuss the results. The dial in numbers are (844) 882-7830 for domestic callers and (574) 990-9704 for international callers. The conference ID is 3264026. A...
Nuvectra® to Participate in Two Upcoming Investor Conferences
Nuvectra® to Participate in Two Upcoming Investor Conferences PLANO, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that members of management are scheduled to participate in two upcoming investor conferences in New York, NY. Event: Raymond James 2019 Life Sciences and MedTech Conference Date: Tuesday, June 18, 2019 Time: 11:30 a.m. ET Location: Lotte New York Palace Hotel Format: Presentation & 1x1 Meetings Event: JMP Securities Life Sciences...
Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body...
Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body MR-Conditional Approval PLANO, Texas, June 11, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has filed its regulatory submission with the U.S. Food and Drug Administration (FDA) for full-body MR-conditional approval for the Company’s Algovita SCS system. Fred Parks, Chief Executive Officer, commented, “We believe full-body MR-conditional approval in the United States, in addition to Algovita’s full-body MR-conditional CE Mark approval,...
- Jonathan Moreland
SKT TANGER FACTORY OUTLET CENTERS INC.
PXLW PIXELWORKS INC.
NVTRQ NUVECTRA
NRIM NORTHRIM BANCORP INC.
LUNA LUNA INNOVATIONS
LCI LANNETT COMPANY INC.
IVAC INTEVAC INC.
IRMD IRADIMED CORP
INO INOVIO PHARMACEUTICALS INC.
IEC IEC ELECTRONICS
HRZN HORIZON TECHNOLOGY FINANCE CORP.
HOO HERBALIFE NUTRITION LTD.
GTT GTT COMMUNICATIONS INC.
CMRX CHIMERIX INC
BOCH BANK OF COMMERCE HOLDINGS
AMRS AMYRIS
ADMA ADMA BIOLOGICS INC
MLVF MALVERN BANCORP
MBCN MIDDLEFIELD BANC CORP
EGY VAALCO ENERGY INC.
PCYG PARK CITY GROUP
SBPH SPRING BANK PHARMACEUTICALS
MTNB MATINAS BIOPHARMA HOLDINGS INC
ORN ORION MINERALS LIMITED
CERC CERECOR INC
HIL HILL INTERNATIONAL
RAIL FREIGHTCAR AMERICA INC.
SITE SITEONE LANDSCAPE SUPPLY INC.
AP AMPCO-PITTSBURGH
KINS KINGSTONE COS. INC.
LCUT LIFETIME BRANDS
NOVN NOVAN INC
NVUS NOVUS THERAPEUTICS INC.
RIBT RICEBRAN TECHNOLOGIES
BBGI BEASLEY BROADCAST GROUP INC. CL A
ESQ ESQUIRE FINANCIAL HOLDINGS
SFIX STITCH FIX CLASS A
RMBL RUMBLEON INC
RDVT RED VIOLET
NICK NICHOLAS FINANCIAL INC.
WLMS WILLIAMS INDUSTRIAL SERVICES GROUP INC.
PRTS U.S. AUTO PARTS NETWORK
SLGG INC.
INMB SUPER LEAGUE GAMING
BSGM INMUNE BIO
EDNT INC.
APRN BIOSIG TECHNOLOGIES INC.
BW EDISON NATION
DRAD BLUE APRON HOLDINGS
WW BABCOCK & WILCOX ENTERPRISES
EVLV DIGIRAD
IDSY WEIGHT WATCHERS INTERNATIONAL
DFRG INC.
EVINE LIVE INC.
I.D. SYSTEMS
INC.
DEL FRISCO'S RESTAURANT GROUP
LLC
Nuvectra Highlights Positive Preliminary Algovita® Clinical Data at t...
Nuvectra Highlights Positive Preliminary Algovita® Clinical Data at the INS 14th Annual World Congress Data Illustrates Below Industry Average Lead Fracture and Migration Rates PLANO, Texas,, May 30, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary Algovita® clinical data from its U.S. and EU multi-center, single-arm study demonstrating lead fracture and migration rates that were below industry average. The study data was presented by Robert Levy, MD, PhD, a board-certified neurological surgeon and membe...
- Jonathan Moreland
VIVO MERIDIAN BIOSCIENCE INC.
SGA SAGA COMMUNICATIONS INC. CL A
OPK OPKO HEALTH INC.
NVTRQ NUVECTRA
LTS LADENBURG THALMANN FINANCIAL SERVICES INC.
INO INOVIO PHARMACEUTICALS INC.
EPC EDGEWELL PERSONAL CARE CO.
OVINTIV INC
LUMN LUMEN TECHNOLOGIES INC.
BG BUNGE LIMITED
ARR ARMOUR RESIDENTIAL REIT INC.
AR ANTERO RESOURCES CORPORATION
ADMA ADMA BIOLOGICS INC
AAWW ATLAS AIR WORLDWIDE HOLDINGS INC.
MLVF MALVERN BANCORP
FRBK REPUBLIC FIRST BANCORP INC.
ELY CALLAWAY GOLF COMPANY
MAC MACERICH COMPANY
TSC TRISTATE CAPITAL HOLDINGS INC
SITE SITEONE LANDSCAPE SUPPLY INC.
AP AMPCO-PITTSBURGH
EHI WESTERN ASSET GLOBAL HIGH INCOME FUND
TPL TEXAS PACIFIC LAND CORPORATION
TPB TURNING POINT BRANDS
AMBC AMBAC FINANCIAL GROUP INC.
NOVN NOVAN INC
CNDT CONDUENT INC.
CLF CLIFFS NATURAL RESOURCES INC.
TDW TIDEWATER INC
WTBA WEST BANCORP INC.
FUND ROYCE FOCUS TRUST
INC.
1 director bought
A director at Nuvectra Corp bought 8,500 shares at 4.250USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Nuvectra® Announces Departure of COO & CFO Walter Z. Berger
Nuvectra® Announces Departure of COO & CFO Walter Z. Berger Appoints Jennifer Kosharek as Interim CFO PLANO, Texas, May 16, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that Walter Z. Berger has resigned as Nuvectra’s Chief Operating Officer and Chief Financial Officer to pursue another business opportunity, effective May 24, 2019. The Board of Directors accepted Mr. Berger’s resignation and has appointed Ms. Jennifer Kosharek, the Company’s current Vice President, Controller and Principal Accounting Officer, as...
- Jonathan Moreland
TA TRAVELCENTERS OF AMERICA
STT STATE STREET CORPORATION
XNCR XENCOR INC.
USAK USA TRUCK INC.
TBK TRIUMPH BANCORP INC.
STRL STERLING CONSTRUCTION COMPANY INC.
SSNC SS&C TECHNOLOGIES HOLDINGS INC.
RRC RANGE RESOURCES CORPORATION
PXLW PIXELWORKS INC.
OPK OPKO HEALTH INC.
NVTRQ NUVECTRA
NCUN CORNERSTONE BUILDING BRANDS INC
MITT AG MORTGAGE INVESTMENT TRUST INC.
LUNA LUNA INNOVATIONS
LCI LANNETT COMPANY INC.
IVZ INVESCO LTD.
IVAC INTEVAC INC.
HMST HOMESTREET INC.
FOE FERRO CORPORATION
EVLV EVINE LIVE
DRAD DIGIRAD CORP.
DFRG DEL FRISCO'S RESTAURANT GROUP
AEL AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
FLR FLUOR CORPORATION
ADC AGREE REALTY CORPORATION
GEL GENESIS ENERGY L.P.
HFC HOLLYFRONTIER CORPORATION
KMI KINDER MORGAN INC CLASS P
MGM MGM RESORTS INTERNATIONAL
RAIL FREIGHTCAR AMERICA INC.
TDC TERADATA CORPORATION
SITE SITEONE LANDSCAPE SUPPLY INC.
EHI WESTERN ASSET GLOBAL HIGH INCOME FUND
RILY B RILEY SECURITIES INC
NHC NATIONAL HEALTHCARE CORP.
JBHT J.B. HUNT TRANSPORT SERVICES INC.
TGE TALLGRASS ENERGY LP CLASS A
MOS THE MOSAIC COMPANY
VVR INVESCO SENIOR INCOME TRUST
NVUS NOVUS THERAPEUTICS INC.
ATNX ATHENEX
JOE ST JOE CO.
TDW TIDEWATER INC
WTBA WEST BANCORP INC.
FUND ROYCE FOCUS TRUST
YETI INC.
RGLS YETI HOLDINGS
PRSP REGULUS THERAPEUTICS
TST PROSPERITY BANCSHARES
INC.
THESTREET
- Jonathan Moreland
TBK TRIUMPH BANCORP INC.
SSNC SS&C TECHNOLOGIES HOLDINGS INC.
RRC RANGE RESOURCES CORPORATION
NVTRQ NUVECTRA
AEL AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
ADC AGREE REALTY CORPORATION
TDC TERADATA CORPORATION
THS TREEHOUSE FOODS INC.
SITE SITEONE LANDSCAPE SUPPLY INC.
EHI WESTERN ASSET GLOBAL HIGH INCOME FUND
TGE TALLGRASS ENERGY LP CLASS A
VVR INVESCO SENIOR INCOME TRUST
JOE ST JOE CO.
PRSP PROSPERITY BANCSHARES
TST INC.
THESTREET
- Jonathan Moreland
Nuvectra® Reports First Quarter 2019 Financial Results
Nuvectra® Reports First Quarter 2019 Financial Results PLANO, Texas, May 01, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31, 2019. Recent Business Highlights Increased Algovita® revenues 22% YoY to $11.0 millionProviding additional information to FDA for Virtis™ PMA submissionAppointed Anthony P. Bihl as Chairman of the Board and elected industry veterans Christopher G. Chavez and Jane J. Song as Directors Fred Parks, Chief Executive Officer, commented, “Our ...
Nuvectra® Appoints Anthony P. Bihl, III as New Chairman of the Board
Nuvectra® Appoints Anthony P. Bihl, III as New Chairman of the Board Elects Jane J. Song to the Board of Directors PLANO, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Anthony P. Bihl, III as Chairman of the Board of Directors, following Dr. Joseph A. Miller’s retirement from the Board, effective immediately. Concurrently, Jane J. Song was appointed as an independent member of the Company’s Board of Directors and as a member of the Board’s Governance and Nomination Committee. ...
Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results
Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results Record Fourth Quarter & Full Year 2018 Algovita® Sales of $14.1 million and $47.1 million, Up 36% and 84% YoY Respectively PLANO, Texas, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the fourth quarter and full year ended December 31, 2018. Recent Highlights Record consolidated revenues of $14.5 million and $48.8 million in the fourth quarter and full year 2018, up 36% and 80% YoY, excluding NeuroNexus revenues ...
Nuvectra® to Present at 39th Annual Cowen Healthcare Conference
Nuvectra® to Present at 39th Annual Cowen Healthcare Conference PLANO, Texas, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Fred Parks, PhD, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at the upcoming 39th Annual Cowen Healthcare Conference in Boston, Massachusetts. Event: 39th Annual Cowen Healthcare ConferenceDate: Tuesday, March 12, 2019Time: 11:20am ETFormat: Presentation a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.